cbioportal: Server-Side Request Forgery
CVE-2024-41668 is a high-severity server-side request forgery vulnerability in cbioportal, with a CVSS 3.1 base score of 8.3 out of 10. It can be exploited remotely over the network by an unauthenticated attacker, without any action from a user. Affected cbioportal versions: < 6.0.12. The record does not name a fixed version, so check the vendor advisory. There is no confirmed exploitation so far. EPSS estimates a 0.58% chance of exploitation within 30 days, which is low compared with other CVEs.
High severity with no evidence of exploitation so far.
What to do
- Update cbioportal to 6.0.12 or a later version.
- Read the advisory on github.com for workarounds and exact fixed builds.
- Until you can update, restrict network access to the affected service so it is not reachable from untrusted networks.
Affected products and versions
| Vendor | Product | Affected versions | Fixed in |
|---|---|---|---|
| cBioPortal | cbioportal | < 6.0.12 | Not stated |
| Cbioportal Project | cbioportal | before 6.0.12 | 6.0.12 |
Version data comes from the organisation that assigned the CVE. Confirm against the vendor advisory before deciding you are unaffected.
How the severity score breaks down
- Attack vector
- NetworkCan be exploited remotely over a network, including the internet.
- Attack complexity
- LowNo special conditions are needed; the attack works reliably.
- Privileges required
- NoneNo account or login is needed.
- User interaction
- NoneNo action by a victim is required.
- Scope
- ChangedThe attack can reach beyond the vulnerable component into other systems.
- Confidentiality
- LowSome restricted data can be read.
- Integrity
- LowLimited modification of data is possible.
- Availability
- LowPerformance or availability is reduced.
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L. Scored by CNA (github.com).
Official description
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.
Source: the CVE record as published by its numbering authority, via NVD and CVE.org.
The underlying weakness: Server-Side Request Forgery
The web server receives a URL or similar request from an upstream component and retrieves the contents of this URL, but it does not sufficiently ensure that the request is being sent to the expected destination.
How developers prevent this class of flaw
- If there is a known list of applications, IP, hostname, and/or domains to which the product is allowed to communicate, then use allowlists to ensure that outgoing requests are restricted to these known entities. The allowlists could be in the application code or possibly enforced by firewalls or network segmentation.
- If the product is expected to be able to connect to arbitrary IP addresses or domains, consider using a denylist that includes private network addresses, internal domain names, etc. The denylist could be in the application code or possibly enforced by firewalls or network segmentation.
Timeline
- CVE record published.
- CISA published its SSVC assessment (exploitation: poc, automatable: yes, technical impact: partial).
- Record last changed materially (score, affected products, status or references).
References
Patches and release notes
Other references
Recent Server-Side Request Forgery vulnerabilities
- 9.1 Critical severity
- 8.2 High severity
- 7.5 High severity
- 7.7 High severity
- 8.8 High severity
- 7.2 High severity
Spotted an error? Tell us.